Document is current
Any future updates will be listed below
-
Authors
Jong, Chiem Leonardo de
Siesling, Sabine
Puts, Ghita Carola Wilhelmina Maria
Jager, Agnes
Ausems, Margreet Geertruda Elia Maria
-
Funding
Funding for this research was provided by:
AstraZeneca (aznl202300195)
- License Information
-
More Information
Article History
Received: 16 April 2025
Accepted: 24 June 2025
First Online: 14 July 2025
Declarations
:
: This study does not fall under the scope of the Dutch Medical Research Involving Human Subjects Act (WMO); this was confirmed by the MEC-U of the UMC Utrecht, which ensures compliance with legislation and regulations (in terms of informed consent, data management, privacy aspects and legal aspects). The request for the use of data has been granted according to the conditions of the privacy committee of the NCR and the NABON-BOOG committee (K23.325).
: CLdJ, GCWMP and AJ declare no conflict of interest. SS received a fee for reviewing grant applications for the Pfizer Boost program. MGEMA received consulting fees from AstraZeneca for participation in an international Steering Committee to give advice on a Train-The-Trainer programme and honoria for a lecture on genetic testing in breast cancer. These payments were made to the institution (University Medical Center Utrecht).
